| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2012) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L04AA31 |
| UNII: | 1C058IKG3B |
| InChI Key | UTNUDOFZCWSZMS-YFHOEESVSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H9F3N2O2 |
| Molecular Weight | 270.21 |
| AlogP | 3.0 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 73.12 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Dihydroorotate dehydrogenase inhibitor | Expert |
| Primary Target | |
|---|---|
| dihydroorotate dehydrogenase (quinone) |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
8900-8913 | 130-5012 | - | 30-2700 | 64 | |
|
Enzyme
|
8900-8913 | 130-5012 | - | 30-2700 | 64 | |
|
Ion channel
Other ion channel
Miscellaneous ion channel
Ca2+ release-activated Ca2+ channel family
|
- | 4300 | - | - | - | |
|
Unclassified protein
|
- | 4300 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Celiac Disease | 1 | D002446 | ClinicalTrials |
| Paraparesis, Tropical Spastic | 1 | D015493 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 163451-81-8 |
| ChEBI | 68540 |
| ChEMBL | CHEMBL973 |
| DrugBank | DB08880 |
| DrugCentral | 4634 |
| EPA CompTox | DTXSID80893457 |
| FDA SRS | 1C058IKG3B |
| Guide to Pharmacology | 6844 |
| KEGG | D10172 |
| PDB | A26 |
| PubChem | 54684141 |
| SureChEMBL | SCHEMBL22661 |
| ZINC | ZINC000013512456 |